Lxo Ireland Designated

Latest clinical program signals indexed for Lxo Ireland Designated.

1. IND 179135 Research — Phase 1

   Jun 8, 2026
   Clinical update →

2. ANDA219975 + ANDA220011 — Phase 3

   Jun 8, 2026
   Clinical update →

3. IND165646 — Phase 1

   Jun 8, 2026
   Clinical update →

4. EudraCT: 2008-004014-27 — Phase 2

   Jun 8, 2026
   Clinical update →

5. CMMo/RH/2009 — Phase 2

   Jun 8, 2026
   Clinical update →

6. FIB-BIO-2023-03 — Phase 2

   Jun 8, 2026
   Clinical update →

7. Topotecan - usual — Phase 3

   Jun 8, 2026
   Clinical update →

8. Stem cell infusion — Phase 2

   Jun 8, 2026
   Clinical update →

1. NCT00629096

   Intracoronary infusion of autologous bone marrow cells

   Phase 2 · completed · other

   Dilated Cardiomyopathy

   CT.gov ↗
2. NCT00685555

   Switch active lifestyles brought to you by MediaWise

   Phase 1 · completed · other

   Overweight

   CT.gov ↗
3. NCT00872326

   Autologous Bone Marrow Mononuclear Cells

   Phase 2 · completed · other

   Peripheral Vascular Diseases

   CT.gov ↗
4. NCT00883584

   IMD-1041

   Phase 2 · active · small_molecule

   Chronic Obstructive Pulmonary Disease

   CT.gov ↗
5. NCT00987363

   Intraarterial infusion of autologous bone marrow cells

   Phase 2 · completed · other

   Critical Limb Ischemia (CLI)

   CT.gov ↗
6. NCT01056471

   Autologous mesenchymal stem cells from adipose tissue.

   Phase 2 · completed · other

   Autoimmune Diseases

   CT.gov ↗
7. NCT01064466

   ETOPOSIDE - Usual

   Phase 3 · active · small_molecule

   Small Cell Lung Cancer

   CT.gov ↗
8. NCT01090856

   Pre-dilation side branch

   Approved · completed · other

   Coronary Angiography

   CT.gov ↗
9. NCT01222039

   EudraCT: 2008-004014-27

   Phase 2 · completed · other

   Graft Versus Host Disease

   CT.gov ↗
10. NCT01257776

    Autologous adipose derived mesenchymal stem cells

    Phase 2 · completed · small_molecule

    Critical Limb Ischemia (CLI)

    CT.gov ↗
11. NCT01397604

    GLA-AF

    Phase 1 · completed · small_molecule

    Healthy Volunteers

    CT.gov ↗
12. NCT01408381

    Intraarterial infusion of autologous bone marrow cells

    Phase 2 · completed · other

    Critical Limb Ischemia (CLI)

    CT.gov ↗
13. NCT01454323

    Bone marrow mononuclear cells

    Phase 2 · completed · other

    Chronic Myocardial Ischemia

    CT.gov ↗
14. NCT01745731

    CMMo/RH/2009

    Phase 2 · completed · other

    Liver Transplant Rejection

    CT.gov ↗
15. NCT01745744

    Mesenchymal stem cells from adipose tissue

    Phase 2 · completed · other

    Critical Limb Ischemia

    CT.gov ↗
16. NCT01745783

    Bone marrow mesenchymal stem cells autologous

    Phase 2 · completed · other

    Multiple Sclerosis

    CT.gov ↗
17. NCT01751243

    Allo-depleted lymphocyte infusion

    Phase 1 · terminated · other

    Transplant-Related Hematologic Malignancy

    CT.gov ↗
18. NCT01761435

    Influenza vaccine

    Phase 3 · completed · mab

    Infection in Solid Organ Transplant Recipients

    CT.gov ↗
19. NCT01765244

    Anterior lamellar nanostructured artificial human cornea.

    Phase 2 · completed · small_molecule

    Severe Trophic Corneal Ulcers Refractory to Conventional Treatment

    CT.gov ↗
20. NCT01765829

    Discontinuation antipsychotic treatment

    Phase 3 · active · small_molecule

    Psychosis Nos/Other

    CT.gov ↗
21. NCT01765842

    Rituximab

    Phase 3 · terminated · mab

    Lupus Nephritis

    CT.gov ↗
22. NCT01849341

    Roflumilast alternated days

    Approved · completed · small_molecule

    Chronic Obstructive Pulmonary Disease (COPD)

    CT.gov ↗
23. NCT01875263

    Cloxacilin

    Phase 3 · terminated · small_molecule

    Staphylococcus

    CT.gov ↗
24. NCT01876407

    Low intensity laser for oral mucositis

    Approved · active · other

    Oral Mucositis

    CT.gov ↗
25. NCT01954927

    Gabapentin

    Phase 2 · completed · small_molecule

    Sickle Cell Disease

    CT.gov ↗
26. NCT02015416

    IDC-G305

    Phase 1 · completed · mab

    Melanoma

    CT.gov ↗
27. NCT02022514

    Conventional medical treatment

    Phase 3 · completed · small_molecule

    Coronary Atherosclerosis and Other Heart Disease

    CT.gov ↗
28. NCT02033278

    Infusion of autologous mononuclear bone marrow cells

    Phase 2 · terminated · small_molecule

    Idiopathic Dilated Cardiomyopathy

    CT.gov ↗
29. NCT02035657

    GLA-SE

    Phase 1 · completed · mab

    Merkel Cell Carcinoma

    CT.gov ↗
30. NCT02073773

    Levodopa

    Phase 3 · completed · small_molecule

    Ischaemic Stroke

    CT.gov ↗
31. NCT02122861

    ID-LV305

    Phase 1 · completed · mab

    Melanoma - Currently Enrolling

    CT.gov ↗
32. NCT02287974

    Stem cell infusion

    Phase 2 · terminated · small_molecule

    Critical Limb Ischemia (CLI)

    CT.gov ↗
33. NCT02290041

    Infusion of MSC

    Phase 2 · completed · small_molecule

    Discordant Immunological Response in HIV Infected Subjects

    CT.gov ↗
34. NCT02290886

    Intravenous administration of 1 million of MSC

    Phase 2 · completed · small_molecule

    Amyotrophic Lateral Sclerosis

    CT.gov ↗
35. NCT02292628

    Infusion of mesenchymal stem cells from adipose tissue

    Phase 2 · completed · small_molecule

    Faecal Incontinence

    CT.gov ↗
36. NCT02303821

    Carfilzomib

    Phase 1 · completed · small_molecule

    Acute Lymphoblastic Leukemia (ALL)

    CT.gov ↗
37. NCT02387125

    CMB305

    Phase 2 · terminated · mab

    Sarcoma

    CT.gov ↗
38. NCT02403505

    CEA protein antigen plus BCG Vaccine Mix for percutaneous use

    Phase 1 · active · mab

    Rectal Cancer

    CT.gov ↗
39. NCT02406781

    Combination of MK3475 with Metronomic CP

    Phase 2 · completed · small_molecule

    Sarcoma

    CT.gov ↗
40. NCT02501473

    G100

    Phase 2 · terminated · small_molecule

    Follicular Low Grade Non-Hodgkin's Lymphoma

    CT.gov ↗
41. NCT02565953

    Paclitaxel-releasing PTA balloon catheter

    Phase 3 · completed · other

    Arteriovenous Fistula Renal Dialysis Devices Obstruction

    CT.gov ↗
42. NCT02609984

    CMB305

    Phase 2 · terminated · mab

    Sarcoma

    CT.gov ↗
43. NCT02687646

    Adult Allogeneic Mesenchymal cells from adipose tissue.

    Phase 2 · completed · small_molecule

    Acute Graft Versus Host Disease

    CT.gov ↗
44. NCT02694146

    Platelet rich plasma

    Phase 3 · completed · small_molecule

    Coxarthrosis

    CT.gov ↗
45. NCT02706119

    Subcutaneous glargine insulin

    Approved · completed · small_molecule

    Diabetes Mellitus

    CT.gov ↗
46. NCT03111238

    REX-001

    Phase 3 · terminated · small_molecule

    Peripheral Arterial Disease (PAD)

    CT.gov ↗
47. NCT03174522

    REX-001

    Phase 3 · terminated · small_molecule

    Peripheral Arterial Disease (PAD)

    CT.gov ↗
48. NCT03305341

    IND165646

    Phase 1 · active · mab

    Covid19

    CT.gov ↗
49. NCT03348670

    Abiraterone - Usual

    Phase 3 · active · small_molecule

    Prostate Cancer

    CT.gov ↗
50. NCT03386630

    Hyperbaric bupivacaine+Sufentanil

    Approved · completed · small_molecule

    Anesthesia; Functional

    CT.gov ↗
51. NCT03386656

    Amchafibrin

    Phase 3 · completed · small_molecule

    Osteoarthritis, Knee

    CT.gov ↗
52. NCT03419806

    Infudopa i.v.

    Phase 1 · completed · small_molecule

    Parkinson Disease

    CT.gov ↗
53. NCT03520959

    LV305

    Phase 3 · terminated · mab

    Synovial Sarcoma

    CT.gov ↗
54. NCT03621475

    Novel restraint

    Phase 1 · completed · other

    Acute Respiratory Failure

    CT.gov ↗
55. NCT04222985

    HSV 2 Formulation 1

    Phase 1 · terminated · mab

    Genital Herpes

    CT.gov ↗
56. NCT04366245

    Hyperimmune plasma

    Phase 2 · completed · mab

    SARS-CoV 2

    CT.gov ↗
57. NCT04366323

    ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS

    Phase 2 · completed · small_molecule

    Sars-CoV2

    CT.gov ↗
58. NCT05234658

    PHITAH

    Phase 2 · active · mab

    Basal Cell Carcinoma

    CT.gov ↗
59. NCT05285540

    DT-216

    Phase 1 · completed · small_molecule

    Friedreich Ataxia

    CT.gov ↗
60. NCT05573698

    DT-216

    Phase 1 · completed · small_molecule

    Friedreich Ataxia

    CT.gov ↗
61. NCT05934825

    Injectable suspension of allogeneic adult mesenchymal stem cells

    Phase 2 · active · mab

    Hidradenitis Suppurativa

    CT.gov ↗
62. NCT05962931

    Bioengineered Artificial Mesenchimal Sheet (BAMS)

    Phase 2 · active · mab

    Venous Ulcer

    CT.gov ↗
63. NCT05987956

    Alectinib - Usual

    Phase 3 · active · small_molecule

    ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

    CT.gov ↗
64. NCT06062810

    Raloxifene - Usual

    Phase 3 · active · small_molecule

    Breast Cancer

    CT.gov ↗
65. NCT06408337

    FIB-BIO-2023-03

    Phase 2 · active · other

    Cleft Lip and Palate

    CT.gov ↗
66. NCT06702332

    MSD-001

    Phase 1 · completed · small_molecule

    Mental Health Disorders

    CT.gov ↗
67. NCT06772870

    DT-216P2

    Phase 2 · active · small_molecule

    Friedreich Ataxia

    CT.gov ↗
68. NCT06874010

    DT-216P2

    Phase 2 · active · small_molecule

    Friedreich Ataxia

    CT.gov ↗
69. NCT06959563

    9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use

    Phase 1 · active · mab

    HPV Infection

    CT.gov ↗
70. NCT07024693

    DT-168

    Phase 2 · active · small_molecule

    Fuchs Endothelial Corneal Dystrophy

    CT.gov ↗
71. NCT07033585

    ANDA219975 + ANDA220011

    Phase 3 · active · small_molecule

    Type 2 Diabetes

    CT.gov ↗
72. NCT07145333

    Topotecan - usual

    Phase 3 · active · small_molecule

    SCLC

    CT.gov ↗
73. NCT07182838

    IND 179135 Research

    Phase 1 · active · mab

    HIV Infections

    CT.gov ↗